CBS News examines common misconceptions about Ozempic, Wegovy, Zepbound
The report addresses what patients and the public most often get wrong about how GLP-1 medicines work.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 16 15:22 ETSource: CBS News
The wire
- 01CBS News published an explainer on widespread misunderstandings about GLP-1 drugs including Ozempic, Wegovy and Zepbound.
- 02Public confusion about GLP-1 mechanisms and expectations affects adherence and demand.
- 03The piece is educational and reports no new study findings.
From the source
Read at news.google.comWhat most people get wrong about GLP-1 drugs like Ozempic, Wegovy and Zepbound